Test MobiusHD device for certain heart failure patients
Part of Heart & circulation clinical trials.
This trial studies whether the MobiusHD® implant can improve symptoms or function in people with heart failure who are still limited in everyday activity. You may be eligible if your heart failure tests show moderate heart weakness and you meet specific walking and lab criteria.
Summary written for real people, not researchers, by Clin2.
Who can take part
- Be age 18 or older
- Have heart failure that is moderate (NYHA Class II or III, or ambulatory Class IV)
- Have a heart pumping measure (left ventricular ejection fraction) of 40% or less
- Have an NT-proBNP blood test level of 400 or higher (shows heart strain)
- Be on stable, best-available heart failure medicines for at least 4 weeks
- Walk between 150 and 400 meters in a 6-minute hall walk test
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This trial is testing a new way to use MRI scans to help people with heart failure who need a special pacemaker called a CRT device. It may help doctors better understand how to treat your heart condition.
This study tests whether using two implanted devices (CardioMems and BaroStim) can improve heart function and symptoms in people with advanced heart failure. It aims to help patients who are already on standard medications get even better results.
This trial studies whether the ContraBand device can be safely placed in people with long-term, symptomatic heart failure and reduced heart pumping. It also looks at whether the approach is practical and tolerable, and gathers early safety information.
This trial is testing a special monitor (BIOMONITOR) that tracks your heart function and sends data wirelessly to your doctor. It aims to help manage heart failure by catching early signs of trouble so you can get treatment sooner.
This trial tests if a combination of a tiny lung-artery pressure sensor (CardioMEMS) and a mechanical heart pump (HeartMate 3) is safe and effective for people with advanced heart failure. If you qualify, you'll either get the heart pump plus standard medical therapy, or continue with standard therapy alone and have your pressure monitored remotely.
This study is looking at how well the CardioMEMS heart monitor works for people with heart failure. The device is already implanted and tracks pressure in your lung artery to help your doctor manage your condition and potentially prevent hospital visits.
Hear when a new Heart Failure With Reduced Ejection Fraction trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.